title: The detection of disease relapse after radical treatment for prostate cancer: is anti-3-18F-FACBC PET/CT a promising option?
authors.forename: Cristina
authors.initials: C
authors.lastname: Nanni
authors.forename: Riccardo
authors.initials: R
authors.lastname: Schiavina
authors.forename: Domenico
authors.initials: D
authors.lastname: Rubello
authors.forename: Valentina
authors.initials: V
authors.lastname: Ambrosini
authors.forename: Eugenio
authors.initials: E
authors.lastname: Brunocilla
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Martorana
authors.forename: Stefano
authors.initials: S
authors.lastname: Fanti
mesh_terms: D002264:Carboxylic Acids; D003503:Cyclobutanes; D006801:Humans; D008297:Male; D064847:Multimodal Imaging; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000000981:diagnostic imaging; D049268:Positron-Emission Tomography; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000628:therapy*; D014057:Tomography, X-Ray Computed
chemical_list: D002264:Carboxylic Acids; D003503:Cyclobutanes; C117460:fluciclovine F-18